|
|
Volumn 10, Issue 9, 2002, Pages 3067-3073
|
|
Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues
a,b
b
b
a,b
c
b
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (4 HEXAHYDRO 1 PYRAZINYLCARBONYLPHENYL) 1,3 ISOINDOLINEDIONE;
2 (4 HEXAHYDRO 1 PYRAZINYLSULFONYLPHENYL) 1,3 ISOINDOLINEDIONE;
2 [4 (1,4 OXAZINAN 4 YLCARBONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
2 [4 (1,4 OXAZINAN 4 YLSULFONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
2 [4 (1,4 THIAZINAN 4 YLCARBONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
2 [4 (1,4 THIAZINAN 4 YLSULFONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
2 [4 (4 METHYLHEXAHYDRO 1 PYRAZINYLCARBONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
2 [4 (4 METHYLHEXAHYDRO 1 PYRAZINYLSULFONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
2 [4 (4 PHENYLHEXAHYDRO 1 PYRAZINYLCARBONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
2 [4 (4 PHENYLHEXAHYDRO 1 PYRAZINYLSULFONYL)PHENYL] 1,3 ISOINDOLINEDIONE;
LIPOPOLYSACCHARIDE;
PHOSPHODIESTERASE INHIBITOR;
PHTHALIMIDE DERIVATIVE;
THALIDOMIDE;
THALIDOMIDE DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;
ANTIINFLAMMATORY AGENT;
DRUG DERIVATIVE;
PHOSPHODIESTERASE III;
PHOSPHODIESTERASE IV;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DRUG DESIGN;
DRUG POTENCY;
DRUG SYNTHESIS;
MALE;
MOUSE;
NEUTROPHIL CHEMOTAXIS;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
BAGG ALBINO MOUSE;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
LUNG LAVAGE;
SYNTHESIS;
STAPHYLOCOCCUS PHAGE 3A;
3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
BRONCHOALVEOLAR LAVAGE FLUID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
LIPOPOLYSACCHARIDES;
MALE;
MICE;
MICE, INBRED BALB C;
NEUTROPHIL INFILTRATION;
PHTHALIMIDES;
STRUCTURE-ACTIVITY RELATIONSHIP;
THALIDOMIDE;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0036310910
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00152-9 Document Type: Article |
|
Times cited : (226)
|
|
References (33)
|
